Delivery Order SPE2DB20D1004-SPE2DB21FF8X7
Award Date 7/30/21
Potential Completion Date 8/2/21
Potential Value $8.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $22,741.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,566,065,418 tablets of the prescription medication Lialda, a 1.2 gram delayed-release tablet, in quantities of 120 per package. This is a firm-fixed price delivery order contract with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,752.94 Firm Fixed Price delivery order is for the drug Lialda, a tablet used to treat ulcerative colitis. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Lialda, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $1,058.76 and a completion date of August 23, 2021. The contract was awarded on August 20, 2021, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,497.49, is for the supply of Lialda DR 1.2 GM Tablet 120S, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of March 17, 2023. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,714.39 firm fixed-price delivery order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,049.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 120 tablets of the prescription medication LIALDA DR 1.2 GM with a completion date of February 2, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,514.61 for the supply of the pharmaceutical product LIALDA DR 1.2 GM TABLET 120S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product Lialda DR 1.2 GM Tablet 120S, with a ceiling value of $3,410.52 and a period of performance through April 12, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.27 Firm Fixed Price Delivery Order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of February 17, 2023 and was awarded on February 16, 2023. This contract is not designated as a set-aside and appears to be part...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIALDA DR 1.2 GM TABLET 120S, which are likely pharmaceutical products. The contract has a ceiling value of $1,712.95 and a completion date of May 19, 2025. It is a firm fixed-price contract and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the...